Advanced Infant Phototherapy Device YR06221: Harnessing Technology for Newborn Care

Product Description

The Infant Phototherapy Unit YR06221 is a state-of-the-art device designed to offer exceptional treatment to newborns suffering from neonatal jaundice. This cutting-edge equipment stands out due to its advanced technical specifications, aimed at optimizing therapy and ensuring the well-being of infants. With a bilirubin radiancy of 3750μw/cm² at 40cm and 3200μw/cm² at 50cm, the unit delivers effective exposure crucial for the reduction of excess bilirubin in the newborn’s blood.

This device is equipped with adjustable lighting intensity at levels of 33%, 67%, and 100%, allowing for customizable treatment sessions tailored to each infant’s specific needs. Furthermore, its built-in white light feature enhances visibility, ensuring that healthcare professionals can monitor the patient effectively during the therapy session. Its compact design features a radiant space of 400×250mm, capable of delivering a uniform light distribution with a radiant uniformity of >0.4, ensuring consistent treatment coverage.

Model YR06221
Bilirubin Radiancy (40cm) 3750μw/cm² (62.5μw/cm²/nm)
Bilirubin Radiancy (50cm) 3200μw/cm² (53μw/cm²/nm)
Lighting Intensity 33%, 67%, 100%
White Light Yes
Power ≤60VA
Wave Length 400nm~550nm
Radiant Space 400×250mm
Radiant Uniformity >0.4
Therapy Time Set 0-99h59m
Height Range 1350mm~1650mm

Market Price

In the current market, advanced infant phototherapy units like the YR06221 model are priced within the range of $1450 to $2250 USD. These prices reflect the technology and quality build that such units offer to healthcare facilities. The investment in a high-performance phototherapy device can significantly enhance the level of care provided in neonatal departments. For precise pricing and to explore purchasing options, our platform, Kalstein Plus, offers an interactive and straightforward quotation system tailored to your needs.

Frequently Asked Questions

What is the primary use of the YR06221 Infant Phototherapy Unit?

The YR06221 is primarily used to treat neonatal jaundice by reducing bilirubin levels in newborns through phototherapy.

How does the adjustable lighting intensity benefit treatments?

The adjustable lighting allows healthcare providers to customize the treatment according to the specific needs and conditions of each infant, ensuring effective therapy.

Is there any special maintenance required for this unit?

Regular cleaning and routine checks should be performed to ensure optimal functioning. The device’s design facilitates easy maintenance with minimal downtime.

Advantages and Disadvantages

Advantages: The YR06221 unit offers several advantages, including adjustable light intensity, ensuring that each infant receives therapy tailored to their needs. Its compact size and efficient power consumption of ≤60VA make it both economical and practical for various healthcare settings. The unit’s superior radiant uniformity and space also contribute to a more effective treatment environment by ensuring even light distribution.

Disadvantages: Despite its many advantages, the YR06221 unit may present challenges such as the need for consistent power supply and periodic technical maintenance to ensure its electronic components are functioning optimally. Also, initial training might be required for staff to fully utilize its advanced settings and features effectively.

Product Use in the Field

In practical settings, the YR06221 Infant Phototherapy Unit is a vital addition to neonatal care. Placed strategically within neonatal wards, it provides essential treatment for newborns with jaundice, using specific wavelengths (400nm~550nm) that optimize the breakdown of bilirubin. Healthcare providers can adjust the unit’s height (1350mm~1650mm) and therapy duration (0-99h59m) to adapt to the different sizes and needs of patients, further enhancing care quality.

The device’s effectiveness is evident in its application, as its use can lead to faster recovery times and reduce potential complications associated with untreated jaundice. By integrating seamlessly into existing care routines, the YR06221 enhances the standard of care offered in hospitals and clinics worldwide.

Recommendations

For optimal use and longevity of the YR06221 Infant Phototherapy Unit, it is crucial to follow some key recommendations. Regularly scheduled maintenance checks ensure the device operates at peak efficiency, reducing the risk of equipment failure. Healthcare facilities should also provide adequate training for staff to maximize the benefits of the unit’s adjustable features.

Furthermore, consider placing the unit in a consistently cooled and well-ventilated room to prevent overheating during extended use. Always monitor the settings and adjust the therapy duration to align with medical guidelines for phototherapy treatments, guaranteeing safe and effective care for newborns.

If you’re in search of a fusion of innovation and quality, you’ve arrived at the right place. At Kalstein, we offer the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each piece with a level of excellence. Our intuitive and agile online purchasing channels are designed for your convenience, ensuring the friendliest prices. Don’t hesitate any longer, we bring science to life, it’s time to be a part of our community. https://kalstein.net/en/product/infant-phototherapy-unit-yr06221/.

We are here to help you

Send us a direct message

If you require a quote, you have a question about any product and / or want to clarify any doubt, contact us.

    PARIS

    Headquarter

    5 rue de Castiglione 75001 Paris – France.
    (+33) 01 70 39 26 50 (Line available in English and French languages)
    (+33) 7 60 83 92 83 (Line available in Spanish and French languages)
    Mail: [email protected]